DK171645B1 - Adenosinderivater samt farmaceutisk præparat - Google Patents

Adenosinderivater samt farmaceutisk præparat Download PDF

Info

Publication number
DK171645B1
DK171645B1 DK145289A DK145289A DK171645B1 DK 171645 B1 DK171645 B1 DK 171645B1 DK 145289 A DK145289 A DK 145289A DK 145289 A DK145289 A DK 145289A DK 171645 B1 DK171645 B1 DK 171645B1
Authority
DK
Denmark
Prior art keywords
compound
formula
compounds
amine
adenosine
Prior art date
Application number
DK145289A
Other languages
Danish (da)
English (en)
Other versions
DK145289D0 (da
DK145289A (da
Inventor
Michael L Edwards
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK145289D0 publication Critical patent/DK145289D0/da
Publication of DK145289A publication Critical patent/DK145289A/da
Application granted granted Critical
Publication of DK171645B1 publication Critical patent/DK171645B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK145289A 1988-03-25 1989-03-22 Adenosinderivater samt farmaceutisk præparat DK171645B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/173,782 US4996308A (en) 1988-03-25 1988-03-25 Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
US17378288 1988-03-25

Publications (3)

Publication Number Publication Date
DK145289D0 DK145289D0 (da) 1989-03-22
DK145289A DK145289A (da) 1989-09-26
DK171645B1 true DK171645B1 (da) 1997-03-03

Family

ID=22633462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK145289A DK171645B1 (da) 1988-03-25 1989-03-22 Adenosinderivater samt farmaceutisk præparat

Country Status (21)

Country Link
US (1) US4996308A (pt)
EP (1) EP0334361B1 (pt)
JP (1) JP2829737B2 (pt)
KR (1) KR0135529B1 (pt)
CN (1) CN1023804C (pt)
AR (1) AR247403A1 (pt)
AT (1) ATE121415T1 (pt)
AU (1) AU606792B2 (pt)
CA (1) CA1322195C (pt)
DE (1) DE68922235T2 (pt)
DK (1) DK171645B1 (pt)
ES (1) ES2074060T3 (pt)
FI (1) FI90877C (pt)
HU (1) HU203561B (pt)
IE (1) IE67543B1 (pt)
IL (1) IL89689A0 (pt)
NO (1) NO171856C (pt)
NZ (1) NZ228422A (pt)
PH (1) PH26776A (pt)
PT (1) PT90080B (pt)
ZA (1) ZA892105B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924424A1 (de) * 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
AU629988B2 (en) * 1989-10-11 1992-10-15 Merrell Dow Pharmaceuticals Inc. Inosine/guanosine derivatives as antineoplastic agents
NZ235577A (en) * 1989-10-11 1993-01-27 Merrell Dow Pharma 4'-vinylhalo-inosine/guanosine derivatives and pharmaceutical compositions thereof
GB8926417D0 (en) * 1989-11-22 1990-01-10 Wellcome Found Heterocyclic compounds
JPH0421682A (ja) * 1990-05-11 1992-01-24 Asahi Chem Ind Co Ltd 2―フルオロネプラノシンaおよびその製造法
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
WO1994021659A1 (en) * 1993-03-18 1994-09-29 Yamasa Corporation Novel 2'-methylidenenucleotide compound, process for producing the same, and pharmaceutical use thereof
WO1996011200A1 (en) * 1994-10-05 1996-04-18 Chiroscience Limited Purine and guanine compounds as inhibitors of pnp
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
CZ9901996A3 (cs) * 1999-06-04 2001-01-17 Ústav organické chemie a biochemie AV ČR Nové 6-fenylpurinové 9-ß-D-ribonukleosidy s antineoplastickým účinkem, jejich použití k přípravě farmaceutických preparátů a farmaceutické přípravky, které je obsahují
AU784794B2 (en) * 1999-06-09 2006-06-22 Anticancer, Inc. Modulators of methylation for control of bacterial virulence
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
CA2410579C (en) * 2000-05-26 2010-04-20 Jean-Pierre Sommadossi Methods and compositions for treating flaviviruses and pestiviruses
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds
KR20040036417A (ko) * 2002-10-25 2004-04-30 정낙신 항암 활성을 갖는 티오뉴클레오시드 유도체 및 이를함유하는 약학적 조성물
JP5002851B2 (ja) * 2005-01-20 2012-08-15 独立行政法人理化学研究所 イミダゾピリジン誘導体
CN102746304B (zh) * 2012-06-21 2014-03-19 成都苑东药业有限公司 一种嘌呤胺类化合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1113851A (en) * 1965-05-29 1968-05-15 Upjohn Co Decoyinine derivatives
US3472837A (en) * 1966-10-10 1969-10-14 Syntex Corp Unsaturated nucleosides and process for their preparation
US3575959A (en) * 1969-05-13 1971-04-20 Merck & Co Inc 5'-substituted ribofuranosyl nucleosides
US3585189A (en) * 1969-06-27 1971-06-15 Syntex Corp Unsaturated nucleosides and processes for their preparation
US3910885A (en) * 1974-03-12 1975-10-07 Syntex Inc 4-Alkoxy nucleosides and intermediates therefore
EP0184365B1 (en) * 1984-12-04 1993-08-04 Eli Lilly And Company Improvements in the treatment of tumors in mammals
GB8708050D0 (en) * 1987-04-03 1987-05-07 Wellcome Found Therapeutic nucleosides
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
KR890014573A (ko) 1989-10-24
EP0334361A2 (en) 1989-09-27
KR0135529B1 (ko) 1998-04-23
CN1023804C (zh) 1994-02-16
ZA892105B (en) 1989-11-29
FI90877B (fi) 1993-12-31
NO891248L (no) 1989-09-26
HUT49367A (en) 1989-09-28
FI891339A0 (fi) 1989-03-21
FI891339A (fi) 1989-09-26
ES2074060T3 (es) 1995-09-01
JP2829737B2 (ja) 1998-12-02
HU203561B (en) 1991-08-28
ATE121415T1 (de) 1995-05-15
AU3173789A (en) 1989-09-28
PT90080B (pt) 1994-06-30
NO171856B (no) 1993-02-01
DE68922235D1 (de) 1995-05-24
DK145289D0 (da) 1989-03-22
PT90080A (pt) 1989-11-10
DK145289A (da) 1989-09-26
PH26776A (en) 1992-10-13
US4996308A (en) 1991-02-26
NO171856C (no) 1993-05-12
CN1036579A (zh) 1989-10-25
EP0334361B1 (en) 1995-04-19
EP0334361A3 (en) 1991-04-03
IE67543B1 (en) 1996-04-17
IE890953L (en) 1989-09-25
IL89689A0 (en) 1989-09-28
DE68922235T2 (de) 1995-08-31
NO891248D0 (no) 1989-03-21
AU606792B2 (en) 1991-02-14
AR247403A1 (es) 1994-12-29
CA1322195C (en) 1993-09-14
NZ228422A (en) 1991-04-26
FI90877C (fi) 1994-04-11
JPH01283285A (ja) 1989-11-14

Similar Documents

Publication Publication Date Title
DK171645B1 (da) Adenosinderivater samt farmaceutisk præparat
JP3142128B2 (ja) 2’,3’―ジデオキシ―2’,2’―ジフルオロヌクレオシド類
DK171844B1 (da) 2'-Halogenmethyliden-cytidin-derivater, deres fremstilling og anvendelse og farmaceutisk præparat indeholdende sådanne derivater samt 2-arylsulfonylhalogenmethyliden-nucleosid
DK166355B (da) Adenosin-derivater samt farmaceutiske praeparater indeholdende saadanne derivater
US4388308A (en) N6 -[(2-Hydroxypropyl)aryl]adenosines
KR0146333B1 (ko) 신규한2'-할로메틸리덴,2'-에테닐리덴 및 2'-에티닐아데노신유도체
KR0139808B1 (ko) 네플라노신 유도체
JPH0656877A (ja) 抗ウイルス活性および抗ガン活性を有する2’−デオキシ−2’,2’−ジフルオロ(2,6,8−置換)−プリンヌクレオシド類およびその中間体
US4315920A (en) Adenosine deaminase inhibitors
CA2302630A1 (en) Purine acyclonucleosides as antiviral agents
US4997925A (en) 5'-deoxy-5',5'-dihalo adenosines and purine analogues
JP2005509641A (ja) 新規ヒドロキシアルキルインドロカルバゾール化合物、その調製方法、およびそれらを含む医薬組成物
US5574021A (en) Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosides
KR870001935B1 (ko) 항포진성을 갖는 뉴클레오시 유도체 및 그의 산부가염의 제조방법
CN112480104A (zh) 硝唑尼特衍生物及其医药用途

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK